Clinical Trials
4
Active:0
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 3
2 (50.0%)Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth Extraction
Phase 3
Recruiting
- Conditions
- Bleeding From TeethBleeding Prophylaxis
- Interventions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Hyloris Developments
- Target Recruit Count
- 280
- Registration Number
- NCT06143787
- Locations
- 🇺🇸
Loma Linda University School of Dentistry, Loma Linda, California, United States
🇺🇸Stamford Therapeutics Consortium, Stamford, Connecticut, United States
🇺🇸JBR Clinical Research (CenExel), Millcreek, Utah, United States
News
No news found